ZA958028B - Compositions and methods for treatig mast-cell mediated conditions - Google Patents
Compositions and methods for treatig mast-cell mediated conditionsInfo
- Publication number
- ZA958028B ZA958028B ZA958028A ZA958028A ZA958028B ZA 958028 B ZA958028 B ZA 958028B ZA 958028 A ZA958028 A ZA 958028A ZA 958028 A ZA958028 A ZA 958028A ZA 958028 B ZA958028 B ZA 958028B
- Authority
- ZA
- South Africa
- Prior art keywords
- treatig
- mast
- compositions
- methods
- cell mediated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/32—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C271/34—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of rings other than six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Molecular Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31226994A | 1994-09-23 | 1994-09-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA958028B true ZA958028B (en) | 1996-04-18 |
Family
ID=23210670
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA958028A ZA958028B (en) | 1994-09-23 | 1995-09-22 | Compositions and methods for treatig mast-cell mediated conditions |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US6022969A (xx) |
| EP (1) | EP0782571A1 (xx) |
| JP (1) | JPH10506390A (xx) |
| KR (1) | KR970706267A (xx) |
| CN (1) | CN1160398A (xx) |
| AU (1) | AU694275B2 (xx) |
| CA (1) | CA2200561A1 (xx) |
| CZ (1) | CZ87097A3 (xx) |
| EE (1) | EE03525B1 (xx) |
| FI (1) | FI971171L (xx) |
| HR (1) | HRP950499B1 (xx) |
| HU (1) | HUT77770A (xx) |
| IL (1) | IL115405A (xx) |
| LT (1) | LT4234B (xx) |
| LV (1) | LV11865B (xx) |
| MX (1) | MX9702125A (xx) |
| NO (1) | NO309605B1 (xx) |
| NZ (1) | NZ294392A (xx) |
| PL (1) | PL183552B1 (xx) |
| RU (1) | RU2159229C2 (xx) |
| SI (1) | SI9520101A (xx) |
| SK (1) | SK37997A3 (xx) |
| TW (1) | TW442478B (xx) |
| WO (1) | WO1996009297A1 (xx) |
| ZA (1) | ZA958028B (xx) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ333713A (en) * | 1996-07-30 | 2000-12-22 | Axys Pharm Inc | Compounds for treating diseases associated with tryptase activity |
| US5968782A (en) * | 1996-12-04 | 1999-10-19 | Brigham And Womens's Hospital, Inc. | Mast cell protease that cleaves fibrinogen |
| US5955431A (en) * | 1997-02-05 | 1999-09-21 | Brigham And Women's Hospital, Inc. | Mast cell protease peptide inhibitors |
| AU8997498A (en) * | 1997-09-05 | 1999-03-29 | Yoshitomi Pharmaceutical Industries, Ltd. | Tryptase inhibitor |
| AU1208999A (en) * | 1997-11-10 | 1999-05-31 | Array Biopharma, Inc. | Compounds which inhibit tryptase activity |
| US6221914B1 (en) * | 1997-11-10 | 2001-04-24 | Array Biopharma Inc. | Sulfonamide bridging compounds that inhibit tryptase activity |
| ATE282607T1 (de) * | 1998-02-06 | 2004-12-15 | Max Planck Gesellschaft | Tryptase-inhibitoren |
| AU2723099A (en) | 1998-02-06 | 1999-08-23 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Tryptase inhibitors |
| IL141654A0 (en) * | 1998-09-04 | 2002-03-10 | Byk Gulden Lomberg Chem Fab | Pyranose derivatives and pharmaceutical compositions containing the same |
| US6362216B1 (en) | 1998-10-27 | 2002-03-26 | Array Biopharma Inc. | Compounds which inhibit tryptase activity |
| US6849605B1 (en) * | 1999-03-05 | 2005-02-01 | The Trustees Of University Technology Corporation | Inhibitors of serine protease activity, methods and compositions for treatment of viral infections |
| AU3731400A (en) * | 1999-03-05 | 2000-09-21 | Trustees Of University Technology Corporation, The | Methods and compositions useful in inhibiting apoptosis |
| EP1208089B1 (en) * | 1999-08-10 | 2004-10-13 | ALTANA Pharma AG | Diazocin-dione derivatives and their use as tryptase inhibitors |
| DE19940389A1 (de) * | 1999-08-25 | 2001-03-01 | Wilex Biotechnology Gmbh | Selektive Inhibitoren des Urokinase-Plasminogen Aktivators |
| CA2384763A1 (en) * | 1999-09-14 | 2001-03-22 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Tryptase inhibitors |
| GB9923710D0 (en) * | 1999-10-08 | 1999-12-08 | Proteus Molecular Design | Chemical compounds |
| AU1413301A (en) * | 1999-11-17 | 2001-05-30 | Sumitomo Pharmaceuticals Company, Limited | Diabetic remedy containing dipiperazine derivative |
| US7015325B2 (en) * | 1999-12-20 | 2006-03-21 | Altana Pharma Ag | Tryptase inhibitors |
| PT1244614E (pt) * | 1999-12-20 | 2004-10-29 | Altana Pharma Ag | Inibidores de triptase |
| WO2001052883A1 (en) * | 2000-01-20 | 2001-07-26 | Amgen Inc. | Inhibitors of protease-activated receptor-2 (par-2) as novel asthma therapeutics |
| US20020045613A1 (en) * | 2000-04-27 | 2002-04-18 | Heinz Pauls | 1-aroyl-piperidinyl benzamidines |
| DK1358182T3 (da) * | 2001-01-31 | 2004-12-20 | Altana Pharma Ag | Diazocin-derivater og anvendelsen deraf som tryptase-inhibitorer |
| JP2004518736A (ja) | 2001-02-21 | 2004-06-24 | アルタナ ファルマ アクチエンゲゼルシャフト | トリプターゼインヒビター |
| CA2438711A1 (en) * | 2001-02-21 | 2002-08-29 | Altana Pharma Ag | Tryptase inhibitors |
| CA2440482A1 (en) * | 2001-03-15 | 2002-09-26 | Altana Pharma Ag | Tryptase-inhibitors |
| WO2002074732A2 (en) * | 2001-03-15 | 2002-09-26 | Altana Pharma Ag | Tryptase-inhibitors |
| US7186855B2 (en) | 2001-06-11 | 2007-03-06 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| US6818787B2 (en) * | 2001-06-11 | 2004-11-16 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| US7232924B2 (en) | 2001-06-11 | 2007-06-19 | Xenoport, Inc. | Methods for synthesis of acyloxyalkyl derivatives of GABA analogs |
| CA2450659A1 (en) | 2001-06-19 | 2002-12-27 | Altana Pharma Ag | Tryptase inhibitors |
| US20060183664A1 (en) * | 2001-12-13 | 2006-08-17 | Toshiaki Takizawa | Pharmaceutical composition for delayed hypersensitivity |
| AU2003218028A1 (en) | 2002-03-08 | 2003-09-22 | Bristol-Myers Squibb Company | Cyclic derivatives as modulators of chemokine receptor activity |
| TW200524849A (en) * | 2003-07-02 | 2005-08-01 | Hoffmann La Roche | Hydroxyalkylamide derivatives |
| RU2276973C2 (ru) * | 2004-01-22 | 2006-05-27 | Общество с ограниченной ответственностью "Лечебно-диагностическая фирма "Медик" | Противовоспалительная мазь с гиполипидемическим эффектом |
| US20050255154A1 (en) * | 2004-05-11 | 2005-11-17 | Lena Pereswetoff-Morath | Method and composition for treating rhinitis |
| TW200815351A (en) * | 2006-05-02 | 2008-04-01 | Astrazeneca Ab | Novel compounds |
| TWI414527B (zh) * | 2010-10-06 | 2013-11-11 | Ind Tech Res Inst | 異山梨糖醇衍生物及包含該衍生物之液晶顯示器 |
| CN102453037B (zh) * | 2010-10-25 | 2014-06-25 | 财团法人工业技术研究院 | 异山梨糖醇衍生物及包含该衍生物的液晶显示器 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR208414A1 (es) * | 1974-11-07 | 1976-12-27 | Rhone Poulenc Ind | Procedimiento para obtener nuevos derivados de la((acil-4piperazinil-1)carboniloxi-5 pirrolinona-2) |
| US4746737A (en) * | 1985-07-26 | 1988-05-24 | Kowa Co., Ltd. | Phenyl guanidinobenzoate derivatives which have protease inhibitory activity |
| US5525623A (en) * | 1993-03-12 | 1996-06-11 | Arris Pharmaceutical Corporation | Compositions and methods for the treatment of immunomediated inflammatory disorders |
| CZ289930B6 (cs) * | 1993-03-12 | 2002-04-17 | Axys Pharmaceuticals, Inc. | Arylové a heteroarylové peptidové deriváty a farmaceutické prostředky je obsahující |
| AU2764495A (en) * | 1994-06-01 | 1995-12-21 | Arris Pharmaceutical Corporation | Compositions and methods for treating mast-cell mediated conditions |
-
1995
- 1995-09-14 EE EE9700089A patent/EE03525B1/xx not_active IP Right Cessation
- 1995-09-14 NZ NZ294392A patent/NZ294392A/xx unknown
- 1995-09-14 US US08/522,157 patent/US6022969A/en not_active Expired - Fee Related
- 1995-09-14 KR KR1019970701960A patent/KR970706267A/ko not_active Ceased
- 1995-09-14 CZ CZ97870A patent/CZ87097A3/cs unknown
- 1995-09-14 EP EP95934993A patent/EP0782571A1/en not_active Withdrawn
- 1995-09-14 CA CA002200561A patent/CA2200561A1/en not_active Abandoned
- 1995-09-14 FI FI971171A patent/FI971171L/fi unknown
- 1995-09-14 SI SI9520101A patent/SI9520101A/sl unknown
- 1995-09-14 WO PCT/US1995/011814 patent/WO1996009297A1/en not_active Application Discontinuation
- 1995-09-14 SK SK379-97A patent/SK37997A3/sk unknown
- 1995-09-14 CN CN95195191A patent/CN1160398A/zh active Pending
- 1995-09-14 RU RU97106347/04A patent/RU2159229C2/ru not_active IP Right Cessation
- 1995-09-14 MX MX9702125A patent/MX9702125A/es not_active IP Right Cessation
- 1995-09-14 JP JP8511002A patent/JPH10506390A/ja not_active Ceased
- 1995-09-14 AU AU37180/95A patent/AU694275B2/en not_active Ceased
- 1995-09-14 HU HU9702059A patent/HUT77770A/hu unknown
- 1995-09-14 PL PL95319587A patent/PL183552B1/pl unknown
- 1995-09-22 HR HR950499A patent/HRP950499B1/xx not_active IP Right Cessation
- 1995-09-22 IL IL11540595A patent/IL115405A/en not_active IP Right Cessation
- 1995-09-22 ZA ZA958028A patent/ZA958028B/xx unknown
- 1995-09-26 TW TW084110031A patent/TW442478B/zh active
-
1997
- 1997-03-20 NO NO971305A patent/NO309605B1/no unknown
- 1997-04-10 LT LT97-065A patent/LT4234B/lt not_active IP Right Cessation
- 1997-04-22 LV LVP-97-70A patent/LV11865B/en unknown
-
1999
- 1999-03-29 US US09/280,227 patent/US6211228B1/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA958028B (en) | Compositions and methods for treatig mast-cell mediated conditions | |
| IL129138A0 (en) | Methods and compositions for immunomodulation | |
| GB9616411D0 (en) | Shampoo compositions and method | |
| GB2348808B (en) | Methods and compositions for desensitisation | |
| GB9615089D0 (en) | Esters and compositions comprising them | |
| AU2113295A (en) | Novel compositions and methods for water treatment | |
| ZA982188B (en) | Compositions and methods for reducing ocular hyper-tension | |
| PL327659A1 (en) | Disinfecting compositions and surface disinfecting methods | |
| PL332415A1 (en) | Ore cleaning compositions and methods | |
| ZA989400B (en) | Method and composition | |
| EP1056456A4 (en) | R-LANSOPRAZOL COMPOSITIONS AND TREATMENTS THEREFOR | |
| ZA9710419B (en) | Compositions and methods for regulating apoptosis | |
| ZA95701B (en) | Rivets-nails and methods for their implementation | |
| EP1056457A4 (en) | S-LANSOPRAZOLE COMPOSITIONS AND METHODS OF USE | |
| PL331423A1 (en) | Muporocin and chlorohexidrin containing compositions | |
| GB9624501D0 (en) | Insecticial compositions and method | |
| ZA959388B (en) | Compositions comprising carbazoles and cyclodextrins | |
| GB2318356B (en) | Composition and method | |
| GB9408342D0 (en) | Method and composition | |
| EP1073332A4 (en) | R-RABEPRAZOL COMPOSITIONS AND METHODS | |
| GB9419087D0 (en) | Method and composition | |
| GB9414888D0 (en) | Method and composition | |
| IL113444A0 (en) | Compositions and methods for treating leukemia | |
| ZA955409B (en) | Keratolytic-wound healing compositions and methods for preparing and using same | |
| GB9601656D0 (en) | Novel composition and method |